Progress on the role of melatonin in dilated cardiomyopathy

doi:10.16352/j.issn.1001-6325.2022.07.1148

Basic & Clinical Medicine ›› 2022, Vol. 42 ›› Issue (7): 1148-1151.doi: 10.16352/j.issn.1001-6325.2022.07.1148

• Mini Reviews • Previous Articles Next Articles

Progress on the role of melatonin in dilated cardiomyopathy

LIU Jia¹, XU Kai², SHI Rui-zheng¹, ZHANG Guo-gang^2*

1. Department of Cardiovascular Medicine, Xiangya Hospital, Central South University, Changsha 410008;
2. Department of Cardiovascular Medicine, the Third Xiangya Hospital, Central South University, Changsha 410013, China

Received:2021-02-09 Revised:2021-06-15 Online:2022-07-05 Published:2022-06-29
Contact: * xyzgg2006@sina.com

Abstract

Abstract: Dilated cardiomyopathy (DCM) is characterized by decreased systolic function and left or biventricular enlargement. There is no single specific medicine to delay the progression of DCM. Melatonin (Mel) plays a key role in many cardiovascular diseases by regulating cell damage, oxidative stress and other pathological processes,delaying myocardial remodeling and protecting cardiac function. There is a close relationship between DCM and Mel. It is confirmed that Mel plays an important role in delaying the progression of DCM.

Key words: melatonin, dilated cardiomyopathy, cardioprotective effect

CLC Number:

R542.2

LIU Jia, XU Kai, SHI Rui-zheng, ZHANG Guo-gang. Progress on the role of melatonin in dilated cardiomyopathy[J]. Basic & Clinical Medicine, 2022, 42(7): 1148-1151.

References 16

[1]	Sinagra G, Elliott P, Merlo M. Dilated cardiomyopathy: so many cardiomyopathies![J]. European Heart J, 2020, 41:3784-3786.
[2]	Gonzaléz-Candia A, Candia A, Figueroa E, et al. Melatonin long-lasting beneficial effects on pulmonary vascular reactivity and redox balance in chronic hypoxic ovine neonates[J]. J Pineal Res, 2020, 68:e12613.http://dx.doi.org/10.1111/jpi.12613.
[3]	Hung M, Yeung H, Lau C, et al. Melatonin attenuates pulmonary hypertension in chronically hypoxic rats[J]. Inter J Mole Sci, 2017, 18.doi.org/10.3390/ijms 18061125.
[4]	Zhou H, Li D, Zhu P, et al. Inhibitory effect of melatonin on necroptosis via repressing the Ripk3-PGAM5-CypD-mPTP pathway attenuates cardiac microvascular ischemia-reperfu-sion injury[J]. J Pineal Res, 2018, 65:e12503.doi.org/10.1111/jpi.12503.
[5]	Slomski A. Melatonin improves sleep in patients with circadian disruption[J]. JAMA, 2018, 320:749.doi.org/10.1001/jama.2018.10903.
[6]	Owino S, Sánchez-Bretaóo A, Tchio C, et al. Nocturnal activation of melatonin receptor type 1 signaling modulates diurnal insulin sensitivity via regulation of PI3K activity[J]. J Pineal Resh, 2018, 64.doi.org/10.1111./jpi.12462.
[7]	Yin J, Li Y, Han H, et al. Melatonin reprogramming of gut microbiota improves lipid dysmetabolism in high-fat diet-fed mice[J]. J Pineal Res, 2018, 65:e12524.doi.org/10.1111/jpi.12524.
[8]	Misaka T, Yoshihisa A, Yokokawa T, et al. Plasma levels of melatonin in dilated cardiomyopathy[J]. J Pineal Res, 2019, 66:e12564.doi.org/10.1111/jpi.12564.
[9]	Xu L, Su Y, Zhao Y, et al. Melatonin differentially regulates pathological and physiological cardiac hypertrophy: Crucial role of circadian nuclear receptor RORα signaling[J]. J Pineal Res, 2019, 67:e12579.doi.org/10.1111/jpi.12579.
[10]	Xie M, Tang Q, Nie J, et al. Porphyromonas gingivalis BMAL1-down regulation aggravates-induced atheros-clerosis by encouraging oxidative stress[J]. Circulation Res, 2020, 126:e15-e29.http://dx.doi.org/10.1161/circresaha.119.315502.
[11]	Liu Y, Li L, Guo S, et al. Melatonin improves cardiac function in a mouse model of heart failure with preserved ejection fraction[J]. Redox Biol, 2018, 18:211-221.
[12]	Odinokova I, Baburina Y, Kruglov A, et al. Effect of melatonin on rat heart mitochondria in acute heart failure in aged rats[J]. Inter J Mol Sci, 2018, 19.doi.org/10.3390/ijms19061555.
[13]	Gürses I, Özeren M, Serin M, et al. Histopathological evaluation of melatonin as a protective agent in heart injury induced by radiation in a rat model[J]. Pathol, Res Pract, 2014, 210:863-871.
[14]	Lu Q, Yi X, Cheng X, et al. Melatonin protects against myocardial hypertrophy induced by lipopolysaccharide[J]. In vitro Cell Devel Biol Animal, 2015, 51:353-360.
[15]	Zhai M, Liu Z, Zhang B, et al. Melatonin protects against the pathological cardiac hypertrophy induced by transverse aortic constriction through activating PGC-1β: in vivo and in vitro studies[J]. J Pineal Res, 2017, 63. doi.org/10.1111/jpi.12433.
[16]	Che H, Wang Y, Li H, et al. Melatonin alleviates cardiac fibrosis via inhibiting lncRNA MALAT1/miR-141-medi-ated NLRP3 inflammasome and TGF-β1/Smads signaling in diabetic cardiomyopathy[J]. FASEB J, 2020, 34:5282-5298.

Progress on the role of melatonin in dilated cardiomyopathy

PDF

Knowledge

Abstract

Cite this article

share this article

References 16

Related Articles 5

Recommended Articles

Metrics

Comments

[1]	YANG Hanyi, NING Jiayi, WANG Xiaolan, ZHANG Yimeng, XIE Tingke, CHEN Yixuan, HAN Jing. Melatonin inhibits H₂O₂-induced oxidative stress and apoptosis marker protein expression in human umbilical vein endothelial cells [J]. Basic & Clinical Medicine, 2024, 44(5): 645-650.
[2]	WANG Xiu-heng, LIU Yao, WU Jie, HU Heng-jing. Effects of melatonin on circadian rhythm and lipid metabolism [J]. Basic & Clinical Medicine, 2020, 40(6): 838-841.
[3]	YANG Gen-huan, WANG Yan, LIAO Peng-zhi, JIA Yu-long. Melatonin attenuates the oxidative injury of smoking rat carotid arteries [J]. Basic & Clinical Medicine, 2020, 40(4): 528-531.
[4]	Min WANG; Bei LI; Guang-huan ZHANG. Effect of melatonin on the inhibition of connective tissue growth factor and remodeling in asthmatic mouse [J]. Basic & Clinical Medicine, 2010, 30(3): 258-262.
[5]	Wei-yi ZHONG; Guo-du TANG; Zhi-hai LINAG. Melatonin post-intervention could promote the expression of thioredoxin-1 in rats pancreatic tissues with acute necrotizing pancreatitis [J]. Basic & Clinical Medicine, 2010, 30(10): 1059-1065.